Intervention Review

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

  1. Maureen M Lawson2,
  2. Adrian G Thomas3,
  3. Anthony K Akobeng1,*

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 19 JUL 2006

Assessed as up-to-date: 4 MAY 2006

DOI: 10.1002/14651858.CD005112.pub2


How to Cite

Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD005112. DOI: 10.1002/14651858.CD005112.pub2.

Author Information

  1. 1

    Royal Manchester Children's Hospital, Manchester, UK

  2. 2

    Central Manchester and Manchester Children's University Hospitals, Department of Paediatric Gastroenterology, Manchester, UK

  3. 3

    Booth Hall Childrens Hospital, Manchester, UK

*Anthony K Akobeng, Royal Manchester Children's Hospital, Oxford Road, Manchester, M13 9WL, UK. akobeng@aol.com. anthony.akobeng@cmft.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JUL 2006

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ibrahim Koral Onal, Effect of steroid sparing agents on the clinical course of ulcerative colitis, European Journal of Internal Medicine, 2014, 25, 2, e19

    CrossRef

  2. 2
    Paweł Kawalec, Alicja Mikrut, Sylwia Łopuch, Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis, Journal of Gastroenterology and Hepatology, 2014, 29, 6
  3. 3
    Rogger Alvaro Bendezú García, Marco Antonio Rodríguez Manrique, Alvaro Hernández Martínez, Marta Lázaro Sáez, Gustavo Oliver Patrón Román, Sergio Amat Alcaraz, Jose Luis Vega Sáenz, Biological therapy for Crohn's disease in a liver transplant patient, Journal of Digestive Diseases, 2013, 14, 10
  4. 4
    Frank A. Wollheim, Monika Ronneberger, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  5. 5
    Sameer D. Saini, Akbar K. Waljee, Peter D.R. Higgins, Cost Utility of Inflammation-Targeted Therapy for Patients With Ulcerative Colitis, Clinical Gastroenterology and Hepatology, 2012, 10, 10, 1143

    CrossRef

  6. 6
    Amanda E. Horn, Jacob W. Ufberg, Appendicitis, Diverticulitis, and Colitis, Emergency Medicine Clinics of North America, 2011, 29, 2, 347

    CrossRef

  7. 7
    Xavier Juanola Roura, Pedro Zarco Montejo, Jesús Sanz Sanz, Santiago Muñoz Fernández, Juan Mulero Mendoza, Luis Francisco Linares Ferrando, Jordi Gratacós Masmitja, Rosario García de Vicuña, Cristina Fernandez Carballido, Eduardo Collantes Estevez, Enrique Batlle Gualda, Rafael Ariza Ariza, Estíbaliz Loza Santamaría, Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in Spondyloarthritis except for Psoriatic Arthritis, Reumatología Clínica (English Edition), 2011, 7, 2, 113

    CrossRef

  8. 8
    Daniel Burger, Simon Travis, Conventional Medical Management of Inflammatory Bowel Disease, Gastroenterology, 2011, 140, 6, 1827

    CrossRef

  9. 9
    Xavier Juanola Roura, Pedro Zarco Montejo, Jesús Sanz Sanz, Santiago Muñoz Fernández, Juan Mulero Mendoza, Luis Francisco Linares Ferrando, Jordi Gratacós Masmitja, Rosario García de Vicuña, Cristina Fernandez Carballido, Eduardo Collantes Estevez, Enrique Batlle Gualda, Rafael Ariza Ariza, Estíbaliz Loza Santamaría, Documento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis, excepto la artritis psoriásica, Reumatología Clínica, 2011, 7, 2, 113

    CrossRef

  10. 10
    Eric G. Boyce, Jenana Halilovic, Oby Stan-Ugbene, Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor, Clinical Therapeutics, 2010, 32, 10, 1681

    CrossRef

  11. 11
    Cary G. Sauer, Subra Kugathasan, Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD, Medical Clinics of North America, 2010, 94, 1, 35

    CrossRef

  12. 12
    Arnold Wald, Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 2010,

    CrossRef

  13. 13
    Cary G. Sauer, Subra Kugathasan, Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD, Gastroenterology Clinics of North America, 2009, 38, 4, 611

    CrossRef

  14. 14
    Kim L. Isaacs, Netter's Internal Medicine, 2009,

    CrossRef

  15. 15
    S.P.L. Travis, E.F. Stange, M. Lémann, T. Øresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, G. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J.McC. Mortensen, F. Penninckx, M. Gassull, European evidence-based Consensus on the management of ulcerative colitis: Current management, Journal of Crohn's and Colitis, 2008, 2, 1, 24

    CrossRef

  16. 16
    Nynne Nyboe Andersen, Sarah Caspersen, Tine Jess, Pia Munkholm, Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: A Danish Crohn Colitis Database study, Journal of Crohn's and Colitis, 2008, 2, 4, 304

    CrossRef

  17. 17
    Jan C Preiss, Antje Timmer, Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease, The Cochrane Library,
  18. 18
    Sushil K Garg, Ashley M Croft, Peter Bager, Helminth therapy (worms) for induction of remission in inflammatory bowel disease, The Cochrane Library,
  19. 19
    Ashley M Croft, Peter Bager, Sushil K Garg, Joel V Weinstock, Helminths for induction of remission in inflammatory bowel disease, The Cochrane Library,
  20. 20
    Brian W Behm, Stephen J Bickston, Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis, The Cochrane Library,
  21. 21
    Nilesh Chande, Yongjun Wang, John K MacDonald, John WD McDonald, Methotrexate for induction of remission in ulcerative colitis, The Cochrane Library,
  22. 22
    Nilesh Chande, John K MacDonald, John WD McDonald, Methotrexate for induction of remission in ulcerative colitis, The Cochrane Library,
  23. 23
    N Chande, JK MacDonald, JWD McDonald, Methotrexate for induction of remission in ulcerative colitis, The Cochrane Library,
  24. 24
    Nilesh Chande, John WD McDonald, John K MacDonald, Josh J Wang, Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis, The Cochrane Library,
  25. 25
    Nilesh Chande, John WD McDonald, John K MacDonald, Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis, The Cochrane Library,
  26. 26
    N Chande, JW McDonald, JK MacDonald, Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis, The Cochrane Library,
  27. 27
    Stephen J Bickston, Brian W Behm, David J Tsoulis, Jianfeng Cheng, John K MacDonald, Reena Khanna, Brian G Feagan, Vedolizumab for induction and maintenance of remission in ulcerative colitis, The Cochrane Library,